Sonnet BioTherapeutics Holdings, Inc. (SONN)

Dec 2, 2025 - SONN was delisted (reason: merged into PURR)

1.260

-1.840 (-59.35%)

Inactive · Last trade price on Dec 2, 2025

SONN Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Equivalents	0.32	0.15	2.27	3.05	27.62	7.35
Cash & Short-Term Investments	0.32	0.15	2.27	3.05	27.62	7.35
Cash Growth	-90.96%	-93.43%	-25.50%	-88.95%	275.81%	20515.10%
Other Receivables	0.6	0.76	0.79	0.72	-	-
Receivables	0.6	0.76	0.79	0.72	-	-
Prepaid Expenses	0.4	1.21	1.68	1.64	1.19	0.29
Total Current Assets	1.32	2.12	4.74	5.41	28.81	7.64
Property, Plant & Equipment	0.08	0.14	0.23	0.3	0.18	0.27
Long-Term Deferred Charges	0.17	0.02	0.05	0.11	-	-
Other Long-Term Assets	0.49	0.49	0.41	-	-	0.08
Total Assets	2.06	2.77	5.43	5.83	28.99	7.99

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Accounts Payable	3.75	2.18	2.2	4.75	3.78	2.06
Accrued Expenses	1.28	0.94	3.23	3.19	2.31	2.06
Short-Term Debt	-	-	-	0	0	0.02
Current Portion of Leases	0.07	0.08	0.07	0.05	0.09	0.08
Current Unearned Revenue	-	-	0.02	0.17	0.52	0.5
Other Current Liabilities	0	0	0	0	-	-
Total Current Liabilities	5.1	3.21	5.52	8.16	6.7	4.72
Long-Term Debt	-	-	-	-	-	0.12
Long-Term Leases	-	0.05	0.13	0.2	0.03	0.13
Total Liabilities	5.1	3.26	5.66	8.37	6.73	4.97

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	125.06	117.2	110.02	88.87	83.95	39.72
Retained Earnings	-128.11	-117.68	-110.24	-91.41	-61.69	-36.71
Shareholders' Equity	-3.05	-0.49	-0.23	-2.54	22.26	3.02
Total Liabilities & Equity	2.06	2.77	5.43	5.83	28.99	7.99

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Total Debt	0.07	0.13	0.2	0.26	0.13	0.35
Net Cash (Debt)	0.25	0.02	2.07	2.8	27.5	7
Net Cash Growth	-92.58%	-99.10%	-25.98%	-89.83%	292.99%	-
Net Cash Per Share	0.09	0.03	15.96	113.31	-	-
Filing Date Shares Outstanding	6.75	3.01	0.38	0.05	0.02	-
Total Common Shares Outstanding	3.33	0.65	0.22	0.03	0.02	-
Working Capital	-3.78	-1.09	-0.79	-2.75	22.11	2.91
Book Value Per Share	-0.91	-0.75	-1.03	-80.59	910.35	-
Tangible Book Value	-3.05	-0.49	-0.23	-2.54	22.26	3.02
Tangible Book Value Per Share	-0.91	-0.75	-1.03	-80.59	910.35	-

SEC Filings: 10-K · 10-Q